Jean-maxime M. Cote

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Impact of Using Biomarkers in Eligibility Criteria in Acute Kidney Injury Randomized Controlled Trials: A Systematic Review and Methodological Meta-Analysis.

Impact of Using Biomarkers in Eligibility Criteria in Acute Kidney Injury Randomized Controlled Trials: A Systematic Review and Methodological Meta-Analysis.

Journal: Kidney medicine

Published: July 25, 2026

A Pilot Randomized Controlled Trial of Ultrasound Evaluation of Fluid Tolerance for Acute Kidney Injury: USE-the-FORCE-for-AKI Trial.

A Pilot Randomized Controlled Trial of Ultrasound Evaluation of Fluid Tolerance for Acute Kidney Injury: USE-the-FORCE-for-AKI Trial.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 21, 2025

Proactive Prescription-Based Fluid Management Versus Usual Care in Critically Ill Patients on Kidney Replacement Therapy (Probe-Fluid): A Pilot Clinical Trial Protocol.

Proactive Prescription-Based Fluid Management Versus Usual Care in Critically Ill Patients on Kidney Replacement Therapy (Probe-Fluid): A Pilot Clinical Trial Protocol.

Journal: Canadian journal of kidney health and disease

Published: September 02, 2025

Comparative Performance of Novel and Standard Urinary Kidney Biomarkers for Prediction of Persistent Severe Acute Kidney Injury and Long-Term Major Adverse Kidney Events.

Comparative Performance of Novel and Standard Urinary Kidney Biomarkers for Prediction of Persistent Severe Acute Kidney Injury and Long-Term Major Adverse Kidney Events.

Journal: American journal of nephrology

Published: July 01, 2025

Clinical Implementation of Urinary Neutrophil Gelatinase-Associated Lipocalin Testing for Diagnosing Acute Kidney Injury in an Academic Tertiary Care Medical Centre.

Clinical Implementation of Urinary Neutrophil Gelatinase-Associated Lipocalin Testing for Diagnosing Acute Kidney Injury in an Academic Tertiary Care Medical Centre.

Journal: Kidney360

Published: March 13, 2025

Trajectories of fluid management after the initiation of renal replacement therapy in critically ill patients: a secondary analysis of the STARRT-AKI trial.

Trajectories of fluid management after the initiation of renal replacement therapy in critically ill patients: a secondary analysis of the STARRT-AKI trial.

Journal: Critical care (London, England)

Published: February 12, 2025

Self-Reported Burden and Health-Related Quality of Life in Acute Kidney Injury Survivors Compared with Patients with Advanced CKD.

Self-Reported Burden and Health-Related Quality of Life in Acute Kidney Injury Survivors Compared with Patients with Advanced CKD.

Journal: Kidney360

Published: August 30, 2024

Primary Care Providers Barriers, Comfort and Awareness in Follow-up Care of Acute Kidney Injury Patients: A Comprehensive Survey on Current Practices.

Primary Care Providers Barriers, Comfort and Awareness in Follow-up Care of Acute Kidney Injury Patients: A Comprehensive Survey on Current Practices.

Journal: Canadian journal of kidney health and disease

Published: June 28, 2024

Achievement of fluid removal targets during intermittent renal replacement therapy in the intensive care unit.

Achievement of fluid removal targets during intermittent renal replacement therapy in the intensive care unit.

Journal: Clinical kidney journal

Published: February 10, 2024

Does Vancomycin-Piperacillin-Tazobactam Cause Pseudo-AKI, True Nephrotoxicity, or Both?

Does Vancomycin-Piperacillin-Tazobactam Cause Pseudo-AKI, True Nephrotoxicity, or Both?

Journal: Chest

Published: May 03, 2023

Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International Survey.

Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International Survey.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: September 29, 2022

A ray of hope in the discord: is adding piperacillin-tazobactam to vancomycin truly more nephrotoxic?

A ray of hope in the discord: is adding piperacillin-tazobactam to vancomycin truly more nephrotoxic?

Journal: Intensive care medicine

Published: August 02, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026